Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04670523
Other study ID # EROCT
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 6, 2023
Est. completion date December 5, 2025

Study information

Verified date March 2023
Source University Hospital Inselspital, Berne
Contact Patrick Dorn, PD
Phone 0041 31 632 37 45
Email patrick.dorn@insel.ch
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The safe conditions for early chest tube removal have been progressively questioned and redefined around reliable digital air flow criteria and extension of liquid threshold accepted. Nevertheless, in current practice, the chest tube remains in restricting early mobilization and optimal compliance with ERAS programme, during the first crucial 24 h after surgery. Thus, to go further, the investigators decide to assess in this study the safety of POD 0 chest tube removal after minor thoracic operations in patients in health condition tolerating operation and anesthesia.


Description:

Chest tube management is a key element of postoperative care after thoracic surgeries for different indications. During the last decade, minimally invasive surgery and enhanced recovery after surgery (ERAS) programmes have radically changed the equation of recovery, contributing to reduce postoperative morbidity and enhance quality of life, but the chest tube remains its Achilles heel, still providing postoperative pain and impairing pulmonary function. In this view, early chest tube removal has been widely promoted not only for its economic benefits on length of stay but also for improving quality of life and potentially reducing postoperative complications. In parallel, the change from traditional chest drainage devices to electronic devices has also enabled a more accurate air leak measurement with reduction of interobserver variability, decreased chest drainage duration and shortened LOS. The safe conditions for early chest tube removal have been progressively questioned and redefined around reliable digital air flow criteria and extension of liquid threshold accepted. Nevertheless, in current practice, the chest tube remains in restricting early mobilization and optimal compliance with ERAS programme, during the first crucial 24 h after surgery. Thus, to go further, the investigators decide to assess in this study the safety of POD 0 chest tube removal after minor thoracic operations in patients in health condition tolerating operation and anesthesia.


Recruitment information / eligibility

Status Recruiting
Enrollment 304
Est. completion date December 5, 2025
Est. primary completion date January 5, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria: 1. Thoracoscopic extra-anatomical lung resection (surgical lung biopsy) 2. Thoracoscopic pleural biopsy 3. Signed consent 4. Age of majority Exclusion Criteria: 1. Anatomical resection 2. Empyema 3. Pleural effusion 4. Pleurodesis 5. Vulnerable persons (Pregnant women, Children and adolescents)

Study Design


Related Conditions & MeSH terms

  • Lung Pathologies of Unclear Etiology

Intervention

Procedure:
Early postoperative day 0 (POD 0) chest tube removal.
Chest tube removal is a standard bedside intervention after lung resections. Its time point is normally defined according a traditional standard airleak threshold. Traditionally, in our department this threshold will be respected not earlier than 1 day after the operation. The patients of the study group are getting their chest tube removed according to our current airleak protocol (Flow <20 mL/ min on digital suction device) but already in the operating room after wound closure (POD 0). If airleak is persisting than chest tube removal will be performed according to the traditional protocol not earlier than on postoperative day 1 (POD 1).
Chest tube removal according to traditional standard protocol not earlier than on postoperative day 1 (POD 1).
Chest tube removal according to traditional standard protocol not earlier than on postoperative day 1 (POD 1).

Locations

Country Name City State
Switzerland University Hospital of Bern, Inselspital Bern

Sponsors (1)

Lead Sponsor Collaborator
University Hospital Inselspital, Berne

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary 1. Pneumothorax requiring chest tube reinsertion Number of patients with pneumothorax requiring chest tube reinsertion after removal of initial chest tube Pneumothorax 2 hours after chest tube removal between postoperative day 0 and 30 (POD 0 - 30)
Primary 2. Pleural effusion requiring thoracocentesis Number of patients with pleural effusion requiring thoracocentesis after removal of first chest tube Pleural effusion 2 hours after chest tube removal between POD 0 and 30
Primary 3. Prolonged air leak > 5 days Number of patients with persisting air leak longer than 5 days Chest tube removal between POD 6 and 30
Primary 4. Re-admission or reoperation due to pleural complication Number of patients re-admitted to a hospital after first hospitalization Up to 1 month after first operation
Secondary 1. Cardiopulmonary complications (Pneumonia, Atrial fibrillation, ARDS) Number of patients with cardiopulmonary complications (Pneumonia, Atrial fibrillation, ARDS) after operation Up to 1 month after initial operation
Secondary 2. Re-operation Number of patients requiring a re-operation after initial operation Up to 1 month after initial operation
Secondary 3. Length of drainage (days) Average of time with chest tube in site Up to 1 month after initial operation
Secondary 4. Length of stay (days) Average of time in hospital Up to 1 month after initial operation